NAME Dr Daniel Speidel
CANCER TYPE Blood Cancer
INSTITUTION Children's Medical Research Institute
STATE New South Wales
GRANT TYPE Other
PROJECT TYPE Research

A novel biomarker for chemotherapy-resistant blood cancers that can guide therapy. This projects aims to validate a family of molecules that was recently discovered as a biomarker of chemotherapy-resistant blood cancers. These studies will determine whether the abundance of these molecules in cancer cells provides prognostic information and can help to choose the most effective therapy in lymphoma, leukaemia and myelodysplastic syndromes.